News

Filter

Current filters:

None

95896 to 95905 of 96563 results

XOMA MERGER RUMORS

16-03-1992

- USA Today has indicated that Xoma Corp is holding merger talks with Pfizer and possibly with Johnson…

Pfizer

US APPRO FOR ISIS' ANTISENSE TRIAL

16-03-1992

- Isis Pharma has received US Food and Drug Administration approval to begin human clinical trials with…

Amino AcidsInjectionPhysostigmine Salicylate

REPLIGEN APPOINTMENT

16-03-1992

- John Kenward takes the newly-created position of chief operating officer at Repligen.

NEW R&D DIRECTOR AT BBG

16-03-1992

- The British Bio-technology Group plc has announced the appointment of Peter Lewis to the newly-created…

UPJOHN "DOWNGRADE"

16-03-1992

Because of concerns regarding side effects and their impact on the sales of Upjohn's sedative Halcion…

HalcionTriazolam

GANZYME'S CEREDASE 1991 SALES

16-03-1992

- Sales of Genzyme's Gaucher's disease treatment Ceredase (alglucerase) in 1991 were $39.6 million, slightly…

Alglucerase InjectionCeredaseGenzyme

LIFEGrOUP CHANGES ACQUISITION PLAN

16-03-1992

After a long period of analysis and negotiation, Italy's LIFEGROUP, founded in 1991, has decided against…

CANLAC LACTULOSE PLANT FOR CANADA

16-03-1992

Canlac Corp of Canada has ann-ounced that it is to build a new pharmaceutical production facility in…

ROFERON-A COULD SAVE SIGHT

16-03-1992

Swiss major Hoffmann-La Roche's Roferon-A (recombinant interferon alfa-2a) may prove to be a useful treatment…

Antihemophilic FactorCoagulation Factor VIIaInterferon alfa-2aRecombinantRocheRoferon-ASandoz

95896 to 95905 of 96563 results

Back to top